DK2399598T3 - Blokade af CCL18 signalering via CCR6 som en terapeutisk mulighed ved fibrotiske sygdomme og cancer - Google Patents

Blokade af CCL18 signalering via CCR6 som en terapeutisk mulighed ved fibrotiske sygdomme og cancer

Info

Publication number
DK2399598T3
DK2399598T3 DK10167496.8T DK10167496T DK2399598T3 DK 2399598 T3 DK2399598 T3 DK 2399598T3 DK 10167496 T DK10167496 T DK 10167496T DK 2399598 T3 DK2399598 T3 DK 2399598T3
Authority
DK
Denmark
Prior art keywords
ccl18
blockade
cancer
fibrotic disease
signaling via
Prior art date
Application number
DK10167496.8T
Other languages
English (en)
Inventor
Gernot Zissel
Joachim Müller-Quernheim
Antje Prasse
Original Assignee
Universitätsklinikum Freiburg
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Universitätsklinikum Freiburg filed Critical Universitätsklinikum Freiburg
Application granted granted Critical
Publication of DK2399598T3 publication Critical patent/DK2399598T3/da

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • C07K14/4701—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals not used
    • C07K14/4702—Regulators; Modulating activity
    • C07K14/4703—Inhibitors; Suppressors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
    • C07K14/715—Receptors; Cell surface antigens; Cell surface determinants for cytokines; for lymphokines; for interferons
    • C07K14/7158—Receptors; Cell surface antigens; Cell surface determinants for cytokines; for lymphokines; for interferons for chemokines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K48/00—Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2500/00—Screening for compounds of potential therapeutic value

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Genetics & Genomics (AREA)
  • Zoology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Molecular Biology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Toxicology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Pulmonology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Cell Biology (AREA)
  • Immunology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
DK10167496.8T 2010-06-28 2010-06-28 Blokade af CCL18 signalering via CCR6 som en terapeutisk mulighed ved fibrotiske sygdomme og cancer DK2399598T3 (da)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
EP10167496.8A EP2399598B1 (en) 2010-06-28 2010-06-28 Blockade of CCL18 signaling via CCR6 as a therapeutic option in fibrotic diseases and cancer

Publications (1)

Publication Number Publication Date
DK2399598T3 true DK2399598T3 (da) 2014-11-03

Family

ID=42735503

Family Applications (1)

Application Number Title Priority Date Filing Date
DK10167496.8T DK2399598T3 (da) 2010-06-28 2010-06-28 Blokade af CCL18 signalering via CCR6 som en terapeutisk mulighed ved fibrotiske sygdomme og cancer

Country Status (5)

Country Link
EP (1) EP2399598B1 (da)
DK (1) DK2399598T3 (da)
ES (1) ES2523265T3 (da)
HK (1) HK1159525A1 (da)
PL (1) PL2399598T3 (da)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2023125793A1 (en) * 2021-12-29 2023-07-06 Nanjing Immunophage Biotech Co., Ltd Anti-ccr6 antibodies and uses thereof

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1422239A3 (en) * 1995-10-24 2004-12-01 Smithkline Beecham Corporation Mobilization of hematopoietic stem cells using a chemokine
AU3395900A (en) * 1999-03-12 2000-10-04 Human Genome Sciences, Inc. Human lung cancer associated gene sequences and polypeptides
AU1453601A (en) * 1999-11-01 2001-05-14 Curagen Corporation Novel polypeptides and nucleic acids encoding same
AU2003267088A1 (en) * 2002-09-11 2004-04-30 Medical College Of Georgia Research Institute, Inc. Chemokine receptor antagonists as therapeutic agents
JP2007501605A (ja) * 2003-08-08 2007-02-01 ジェノバ・リミテッド 心血管疾患に関連する分泌ポリペプチド種
US20100143949A1 (en) * 2006-10-31 2010-06-10 George Mason Intellectual Properties, Inc. Biomarkers for colorectal cancer

Also Published As

Publication number Publication date
EP2399598A1 (en) 2011-12-28
HK1159525A1 (en) 2012-08-03
EP2399598B1 (en) 2014-08-06
ES2523265T3 (es) 2014-11-24
PL2399598T3 (pl) 2015-02-27

Similar Documents

Publication Publication Date Title
DK2914633T3 (da) Antistof/lægemiddel-konjugater og anvendelsesfremgangsmåder
BRPI1010644A2 (pt) inibidores da replicação do vírus da imunodeficiência humana
CY2014006I1 (el) Μεθοδοι θεραπευτικης αγωγης χρησιμοποιωντας γλυκοπεγκυλιωμενο g-csf
BR112014009634A2 (pt) preparação e agente terapêutico
DK3608325T3 (da) Polycykliske-carbamoylpyridonforbindelser og deres farmaceutiske anvendelse
DK2507211T3 (da) Apoptosefremkaldende midler til behandling af cancer og immun- og autoimmun-sygdomme
DK2511264T3 (da) Apoptose-inducerende midler til behandling af cancer og immunsygdomme og autoimmune sygdomme
DK3622815T3 (da) Gnavermodeller og terapeutiske molekyler
DK2437762T3 (da) Kunstige tårer og terapeutiske anvendelser
DK2579877T3 (da) Morpholinopyrimidiner og deres anvendelse til terapi
BR112013011968A2 (pt) composição farmacêutica, métodos de tratamento e usos da mesma
BR112012018947A2 (pt) composição farmacêutica para tratamento e\ou prevenção do cancêr
BRPI0821779A2 (pt) tratamento terapêutico de câncer
BRPI1011587A2 (pt) compostos e composições terapèuticas
SMT201200009B (it) Terapia con pirfenidone che evita la fluvoxamina
BRPI0810481A2 (pt) Novas asparaginases e usos destas
BR112014006419A2 (pt) métodos para tratar um paciente com câncer, kit e artigo
DK4104848T3 (da) Sikker indgivelse af desmopressin
ITTO20110641A1 (it) Composizioni farmaceutiche e metodi di trattamento
DE112010004110T8 (de) Neue parasitentherapie
BRPI0917684A2 (pt) método terapêutico homeopático
DK3211005T3 (da) Terapeutisk anvendelse af specifik ligand i msrv-associerede sygdomme
SMT201600263B (it) Regimi terapeutici
DK3884947T3 (da) Forøgelse af lægemiddelbiotilgængelighed i naltrexonterapi
BRPI0922653A2 (pt) preparação farmacêutica